๐๏ธ Verified NIH Record โข Updated 2026-07-16
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma (NCT05010629)
Phase 2 Study of 9-ING-41, a Glycogen Synthase Kinase 3 Beta (GSK 3ฮฒ) Inhibitor, Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma
๐ต Active, Not Recruiting Phase2 ๐ Investigational Drug / Biologic Sponsor: Glenn J. Hanna
๐ฉบ Plain-English Summary (8th-Grade Level)
This trial is investigating an intravenous (IV) medication called 9-ING-41 in combination with chemotherapy (carboplatin) for the treatment of advanced salivary gland cancers. The names of the study drug(s) involved in this study are: * 9-ING-41 (a GSK-3ฮฒ inhibitor) * Carboplatin chemotherapy
Who can join: Review the eligibility criteria below.
Location: Brigham and Women's Hospital โ Boston, Massachusetts
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- Brigham and Women's Hospital โ Boston, Massachusetts
- Dana Farber Cancer Institute โ Boston, Massachusetts
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Salivary Gland Cancer
- Amivantamab in Adenoid Cystic Carcinoma โ La Jolla, California
- Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas โ Atlanta, Georgia
- Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers โ Boston, Massachusetts
- A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers โ Boston, Massachusetts
Explore by condition: All Salivary Gland Cancer clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.